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ABSTRACT 
 
In the post-genomic era, there is an increasing interest in visualizing the expression of functional genes in 
vivo. With the assistance of the reporter gene technique, various imaging modalities have been adopted for 
this purpose.  In vivo gene expression imaging promises to provide biologists with a powerful tool for 
deepening our understanding of developmental biology, expanding our knowledge of the genetic basis of 
disease, and advancing the development of medicine. In this paper, we demonstrate the feasibility of 
imaging gene expression with photoacoustic imaging, which offers unique absorption contrast with 
ultrasonic resolution in vivo. We mark tumors in rats with the lacZ reporter gene. The lacZ gene encodes an 
enzyme β-galactosidase, which yields a dark blue product when acting on a colorimetric assay called X-gal. 
Photoacoustic tomography is able to visualize the presence of this blue product clearly in the far red range 
of the optical spectrum. Considering how many staining methods are used in traditional biology, we believe 
that photoacoustic techniques will revolutionize the field of molecular imaging. The further development of 
reporter gene systems with high absorbing products in the NIR region is needed. 
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1. INTRODUCTION 
 
Thanks to the Human Genome Project1, we now have a book of human genetic codes in hand. However, in 
the post-genome era, the bigger challenge of deciphering these codes is still ahead. As a branch of the 
emerging field of molecule imaging, a series of imaging modalities have recently been exploited to image 
the activities of functional genes in vivo, including Positron Emission Tomography (PET), Single Photon 
Emission Tomography (SPECT) and Magnetic Resonance Imaging (MRI).2 These techniques have a 
significant advantage, compared to the widely used ex-vivo methods like DNA micro-array, because they 
have the capabilty to visualize the expression of genes in their natural environment as a dynamic process.  
For our purposes, an extraneous “reporter gene” is usually incorporated into the genome of cells or a 
particular animal model. The protein product of this gene can provide the required contrast for a certain 
imaging modality either directly or by acting on a biochemical assay. It is called a “reporter gene” because 
its expression is related to the function of a promoter or enhancer, the activity of another endogenous gene 
of interest, or the presence of marked cells, etc. Recently, optical methods have attracted interest in this 
field because of their intrinsic rich contrast, high sensitivity, low cost, and ease of operation. Some 
successful paradigms include fluorescence and bioluminescence.3 
    The main challenge to these optical techniques is the high scattering in biological tissue. In this paper, 
we propose, for the first time to our knowledge, photoacoustic tomography (PAT) as a promising candidate 
for imaging gene expression in vivo, which we believe will open a new horizon in this field. PAT relies on 
optical absorption. The photoacoustic waves generated by laser-induced thermo-elastic expansion in 
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absorbing subjects are detected by ultrasonic transducers under certain geometries. The absorbing 
structures are then mapped by coherent reconstruction. In addition to being a non-invasive imaging 
modality, PAT combines the merits of high sensitivity to absorbing contrast and high ultrasonic resolution 
at the sub-millimeter level. G. Ku et al.4  have achieved a penetration depth of several centimeters in tissue 
phantoms. Success has been achieved in depicting both healthy and malignant vasculature in the brains of 
small animals, like rats and mice, which are the popular animal models for molecular imaging.5,6 Functional 
imaging of the level of the oxygen saturation in blood is also possible with photoacoustic techniques5,7. 
Desirable contrast agents provide high optical absorption, preferably in the far-red or near-infrared range, 
where light has the deepest penetration in tissue. Some of these, such as indocyanine green (ICG)8, 
poly(ethylene glycol)-coated nanoshells,9 have been used in in vivo applications 
    We chose the lacZ reporter gene, a classical bacterial reporter gene, for our first attempt at imaging gene 
expression using PAT. It encodes an enzyme, β-galactosidase, which cleaves glycosidic linkages in certain 
sugars, like lactose. Only a few studies have reported to see the expression of the lacZ gene in vivo. The 
first was done using MRI by Louie by introducing a novel β-galactosidase –cleavable paramagnetic contrast 
agent into an embryo of Xenopus at the two-cell stage.10 Recently, Tung  et al used a fluorescence dye, 
DDAOG to image the expression of lacZ using planar fluorescence in mice.11 We used a sensitive 
chromogenic assay, containing primarily a lactose-like sugar called 5-bromo-4-chloro-3-indolyl-β-D-
galactoside (X-gal), to delineate the expression pattern of the lacZ gene. A stable dark blue product was 
generated after the X-gal was cleaved.12 The lacZ/X-gal strategy was previously used widely in genetics 
studies as an important histochemical method in dissected tissue samples or embryos. 
 
    2. MEASUREMENT OF ABSORPTION SPECTRUM 
 
To choose the proper wavelength for imaging, we measured the molar extinction spectrum of the blue 
product, which is reported on here for the first time to our knowledge. 9L/lacZ gliosarchoma tumor cells 
(cultured from cell line from American Type Culture Collection) were washed and centrifuged with cell 
lysate. The supernatant containing β-galactosidase was divided into 5 cuvettes with 120µl each. Then they 
were diluted by 600µl of water. To the first four cuvettes, we added 20µl of X-gal solution (Fermentas, Inc) 
with concentrations of 2, 0.4, 0.2, and 0.04 mg/mL respectively. 20µl of water was added to the last cuvette 
for a baseline. After allowing enough time for reaction, the absorbance of these solutions was measured 
using a spectrometer (USB2000, Ocean Optics, Inc.) with a broadband light source (SOL-R 150DC). 
Because the small amount of X-gal is used, we assumed all of X-gal molecules were cleaved, and thus the 
concentration of blue product can be calculated. Molar extinction coefficients at certain wavelengths were 
obtained from the slope of the linear fitting between the absorbance and the concentration of the blue 
product. In Figure 1, we compared the measured molar extinction spectrum of the blue product with blood 
which has the oxygen saturation (SO2) level at 90%. The blue product has absorption peak, which is 
stronger than blood, around 620-690nm. This is at the far red range of the optical spectrum which means it 
potentially enables deep penetration. 
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Figure 1. Comparison of molar extinction spectrum of the blue product and blood with 90% SO2. 
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3. ANIMAL EXPERIMENTS 
 
3.1 Cells and animals 
    9L/LacZ gliosarchoma tumor cells were cultured until they were ~ 70% confluent. About 5 million cells 
were inoculated subcutaneously under the scalps of Sprague Dawley rats and left to grow until a small 
tumor was present. Hair on the head was removed before imaging. Animals were kept under anaesthesia by 
a gas anesthesia machine (E-Z Anesthesia, Euthanex Corp.) using isoflurane during the experiments. The 
blood oxygenation and heart rates were monitored using a pulse-oximeter (NONIN 8600V). 25µl of X-gal 
(Fermentas, Inc.) was injected subcutaneously near the tumor. A control injection of X-gal was injected in a 
non-tumor location, usually in a symmetric position on the other side of the head to avoid any confusion 
arising from the possible existence of endogenous β-galactosidase. Another photoacoustic image was taken 
afterwards. 
 
3.2 System Setup 
    The scheme of our PAT system setup is shown in Figure 2. A Q-switched Nd:YAG laser (Quantel 
Brilliant B) at 532nm was used to pump a dye laser (Continuum ND6000). We chose laser dye DCM 
(Exciton Inc., Dayton, OH), which provided us a broad range of wavelengths from 608 to 689nm. The 
output of the dye laser was directed using prisms. Before it reached the animal, a concave lens and ground 
glass were employed to broaden the illumination. The laser energy was measured to be about 5mJ/cm2 at 
the imaging plane. An ultrasonic transducer (V323-SU, Panametrics-NDT) with a center frequency of 
2.25MHz was scanned by a customized mechanical gantry system, driven by a stepper motor, around a 
circle to receive the outgoing photoacoustic waves at 240 step locations. Signals were later amplified by 
pre-amplifiers made from broadband RF amplifiers (ZFL500, Mini-circuits Inc.), digitized and averaged at 
each scan position using a digital oscilloscope (TDS5034, Tektronix), and then transferred to a PC. To 
compensate for the fluctuation, a photo-diode (DET110, ThorLabs, Inc.) was used to record the relative 
incident laser power at each position. Signals were triggered by Q-switch synchronization. A program in 
LabVIEW was used to control the stepper motor, change the wavelengths from the dye laser, and acquire 
the data.  
 
 
Figure 2. Scheme of the photoacoustic tomography system. 
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3.3 Image Reconstruction 
    Images were reconstructed following a modified back-projection algorithm13 from the collected 
sinogram, which represents the spatial distribution of the absorption coefficients, under assumptions of 
uniform illumination and homogenous mechanical properties in soft tissues. 
 
 
3.4 Results 
    Figure 3 shows a typical result of photoacoustic imaging at 635nm. Figure 3(a) shows the top view of the 
intact rat head before imaging. The tumor in this case is flat and is hardly visible from outside. The marked 
region is where we imaged. Other parts of the head are covered by a white cloth to protect the eyes of the 
animal and reduce interference signals. Figure 3(b) shows the flipped skin corresponding to the dashed 
rectangular region. The black region is dark blue in color, which represents the region of the tumor with the 
blue product as a result of the expression of the lacZ gene. Figure 3(c) is a photoacoustic image taken 
before the injection of the X-gal. The vasculature of the brain is visible. The relatively strong middle line is 
the image of the median fissure. No obvious sign of a tumor appears. Figure 3(d) shows the image taken 
after the X-gal injection. The tumor shows up dramatically and overwhelms the signal from blood. Its 
shape is similar to the histological view. 
 
              
 
Figure 3. Results from single-wavelength photoacoustic tomography at 635nm. (a) Top view of the intact rat head. (b) 
Flipped skin of the dashed rectangular region; the tumor region is dark blue in color. (c) Photoacoustic image before the 
injection of X-gal. (d) Photoacoustic image after the injection of X-gal. 
 
 
 
4. DISCUSSION 
 
Because of the dominant absorption of the blue product, the expression of the lacZ gene is clearly imaged 
at 635nm in our animal model. This implies the high efficiency of the generation of the blue product. An 
important advantage of the enzyme-based reporter gene systems (e.g. lacZ) over others (e.g. Green 
Fluoresence Protein) is their intrinsic amplification mechanism. A molecule of the expressed product is 
capable of acting on a huge number of probing molecules, and, thus, signal amplification is achieved. 
Potentially, by exploiting the spectroscopic information of optical absorption, a multi-wavelength technique 
with careful calibration will be able to separate the contributions from different absorbers, which will be 
especially helpful when we have low levels of expression. 
    The spatial resolution of the current system was estimated by imaging a phantom with two crossed hairs. 
The smallest separable distance between the centers of the two hairs in the image is about 400µm. The 
sensitivity is estimated by taking A-line measurements of a small tube at 650nm, filled by a solution of blue 
product at a concentration of 0.27 Molar, embedded 5mm deep in chicken tissue. The SNR was calculated 
to be around 75. This means we had a sensitivity better than 3.6 µMolar for the blue product. The 
sensitivity for the expressed products, β-galactosidase, should be much higher than this due to the 
amplification mechanism. The resolution can be improved by adopting high-frequency transducers, at the 
cost of losing sensitivity. Due to the slow pulse repetition rate (PRF) of the laser at 10Hz and the 
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mechanical scanning scheme, it took about 25 minutes to achieve one single-wavelength image. The speed 
can be improved by employing a high PRF laser and transducer array techniques. 
    There are some limitations to in vivo application of X-gal. It appears to cause skin irritation occasionally. 
The dynamics of the reaction needs oxidation14 and is poorly understood in vivo. Currently, we deliver X-
gal by local injection. Systemic delivery of X-gal through the tail vein does not seem efficient in our animal 
model. There are a huge number of staining methods used in traditional biology, and an enormous number 
of pigments existing in nature. Further development of new reporter gene systems providing absorption 
contrast can be expected. It is preferable that the absorption of the reaction products have peaks in the far 
red and near-infrared regions of the optical spectrum, where light can penetrate deep into the tissues.  
    Progress in techniques for imaging gene expression will advance gene therapy where monitoring the 
delivery efficiency of therapeutic genes is a big challenge. 
  
 
5. CONCLUSION 
 
In summary, we have demonstrated the feasibility of imaging gene expression by photoacoustic imaging. 
The expression of lacZ is visualized in the far red range of optical spectrum by photoacoustic tomography. 
We believe this technique will open new horizons in this field and lead to the future development of new 
absorption-based reporter gene systems. 
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